International workshop on lessons from animal models for human type 1 diabetes - Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice

被引:91
作者
Bonifacio, E
Atkinson, M
Eisenbarth, G
Serreze, D
Kay, TWH
Lee-Chan, E
Singh, B
机构
[1] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA
[2] Ist Sci San Raffaele, Dept Med, Milan, Italy
[3] Diabet Res Inst, Munich, Germany
[4] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[5] Jackson Lab, Bar Harbor, ME 04609 USA
[6] Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Melbourne, Vic, Australia
[7] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada
关键词
D O I
10.2337/diabetes.50.11.2451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several self-antigens have been reported as targets of the autoimmune response in nonobese diabetic (NOD) mice. The aim of this workshop was to identify autoantibody assays that could provide useful markers of autoimmunity in this animal model for type I diabetes. More than 400 serum samples from NOD (4, 8, and 12 weeks of age and at diabetes onset), BALB/c, and B6 mice were collected from six separate animal facilities, coded, and distributed to five laboratories for autoantibody measurement. Insulin autoantibodies (IAA) were measured by radiobinding assay (RBA) by four laboratories and by enzyme-linked immunosorbent assay (ELISA) in one laboratory. Using the 99th percentile of BALB/c and B6 control mice as the threshold definition of positivity, IAA by RBA were detected in NOD mice at frequencies ranging from 10 to 30% at age 4 weeks, from 26 to 56% at 8 weeks, from 42 to 56% at 12 weeks, and from 15 to 75% at diabetes onset. With ELISA, IAA signals differed significantly between control mouse strains and increased with age in both control and NOD mice, with frequencies in NOD animals being 0% at 4 weeks, 14% at 8 weeks, 19% at 12 weeks, and 42% at diabetes onset. For IAA, the ELISA results were relatively discordant with those of RBA. GAD autoantibody (GADA) and IA-2 autoantibody (IA-2A) signals obtained by RBA were low (maximum 2.5% of total) but were increased in NOD mice compared with control mice at diabetes onset (GADA 29-50%; IA-2A 36-47%). ELISA also detected GADA (42%) and IA-2A (50%) at diabetes onset, with results concordant with those of RBA. Remarkably, GADA and IA-2A frequencies varied significantly with respect to the source colony of NOD mice. Furthermore, whereas neither GADA nor IA-2A correlated with IAA, there was strong concordance between GADA and IA-2A in individual mice. Sera with increased binding to GAD and IA-2 also had increased binding to the unrelated antigen myelin oligodendrocyte glycoprotein, and binding to GAD could not be inhibited with excess unlabeled antigen, suggesting nonspecific interactions. In sum, this workshop demonstrated that IAA measured by sensitive RBA are a marker of autoimmunity in NOD mice and draw into question the true nature of GADA and IA-2A in this animal model.
引用
收藏
页码:2451 / 2458
页数:8
相关论文
共 22 条
[1]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[2]   ASSESSMENT OF PRECISION, CONCORDANCE, SPECIFICITY, AND SENSITIVITY OF ISLET CELL ANTIBODY MEASUREMENT IN 41 ASSAYS [J].
BONIFACIO, E ;
BOITARD, C ;
GLEICHMANN, H ;
SHATTOCK, MA ;
MOLENAAR, JL ;
BOTTAZZO, GF .
DIABETOLOGIA, 1990, 33 (12) :731-736
[3]   SERUM EXCHANGE AND USE OF DILUTIONS HAVE IMPROVED PRECISION OF MEASUREMENT OF ISLET CELL ANTIBODIES [J].
BONIFACIO, E ;
LERNMARK, A ;
DAWKINS, RL ;
ARNAIZVILLENA, A ;
BARBOSA, J ;
BETTERLE, C ;
BOEHM, B ;
BOITARD, C ;
BOTTAZZO, GF ;
BRIGHT, GM ;
CHAPEL, H ;
DIMARIO, U ;
EISENBARTH, GS ;
ELLIOT, RB ;
GERBITZ, K ;
GLEICHMAN, H ;
HARRISON, L ;
HELMKE, K ;
HULINSKY, I ;
KOBAYASHI, T ;
KUMAR, WJ ;
LANDIN, M ;
MOLENAAR, JL ;
PALMER, JB ;
PETER, JB ;
REINAUER, KM ;
SCOTT, RS ;
SCOTTMORGAN, L ;
SCHERBAUM, WA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 106 (01) :83-88
[4]   Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity [J].
Dighiero, G ;
Rose, NR .
IMMUNOLOGY TODAY, 1999, 20 (09) :423-428
[5]   PROGRESS TOWARD STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODY-ASSAY [J].
GLEICHMANN, H ;
BOTTAZZO, GF .
DIABETES, 1987, 36 (05) :578-584
[6]  
Gottlieb PA, 1998, ANNU REV MED, V49, P391
[7]   INSULIN AUTOANTIBODIES MEASURED BY RADIOIMMUNOASSAY METHODOLOGY ARE MORE RELATED TO INSULIN-DEPENDENT DIABETES-MELLITUS THAN THOSE MEASURED BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY - RESULTS OF THE 4TH INTERNATIONAL WORKSHOP ON THE STANDARDIZATION OF INSULIN AUTOANTIBODY MEASUREMENT [J].
GREENBAUM, CJ ;
PALMER, JP ;
KUGLIN, B ;
KOLB, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1040-1044
[8]   IMPROVED SPECIFICITY OF ICA ASSAYS IN THE 4TH INTERNATIONAL-IMMUNOLOGY-OF-DIABETES-SERUM-EXCHANGE-WORKSHOP [J].
GREENBAUM, CJ ;
PALMER, JP ;
NAGATAKI, S ;
YAMAGUCHI, Y ;
MOLENAAR, JL ;
VANBEERS, WAM ;
MACLAREN, NK ;
LERNMARK, A .
DIABETES, 1992, 41 (12) :1570-1574
[9]   5TH INTERNATIONAL SERUM EXCHANGE WORKSHOP FOR INSULIN AUTOANTIBODY (IAA) STANDARDIZATION [J].
GREENBAUM, CJ ;
WILKIN, TJ ;
PALMER, JP ;
AGOPIAN, MS ;
ARNAIZVILLENA, A ;
BECKER, D ;
BECKER, F ;
BOSI, E ;
BOTTAZZO, GF ;
BOUIX, O ;
COLMAN, P ;
DAWKINS, RL ;
DELEIVA, A ;
DEAN, BM ;
DIMARIO, U ;
EISENBARTH, GS ;
ELLIOT, RB ;
GORUS, F ;
HUANG, W ;
HUMBEL, R ;
JULIA, MR ;
KARJALAINEN, J ;
KEILACKER, H ;
KUGLIN, B ;
KWAN, J ;
LEVYMARCHAL, C ;
MACLAREN, N ;
MCEVOY, RC ;
MOLENAAR, JL ;
REINAUER, KM ;
SCHERBAUM, W ;
SODOYEZ, JC ;
VIALETTES, B ;
ZANCHETTA, R ;
ZIEGLER, AG .
DIABETOLOGIA, 1992, 35 (08) :798-800
[10]  
Haskins Kathryn, 2001, Journal of Autoimmunity, V16, P15, DOI 10.1006/jaut.2000.0467